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Abstract. 
 
Tumor cell migration through the three-
dimensional extracellular matrix (ECM) environment 
is an important part of the metastatic process. We have 
analyzed a role played by the integrin–tetraspanin pro-
tein complexes in invasive migration by culturing 
MDA-MB-231 cells within Matrigel. Using time-lapse 
video recording, we demonstrated that the Matrigel-
embedded cells remain round and exhibit only limited 
ability for migration by extending short, highly dynamic 
 
pseudopodia. The 
 
a
 
3
 
b
 
1–tetraspanin protein complexes 
were clustered on the thin microvilli-like protrusions 
extending from both the main cell body and pseudopo-
dia. Ligation of the 
 
a
 
3
 
b
 
1–tetraspanin protein com-
plexes with monoclonal antibodies speciﬁcally stim-
ulates production of matrix metalloproteinase 2
(MMP-2) and induces formation of long invasive pro-
trusions within Matrigel. Accordingly, treatment with 
the monoclonal antibodies to various tetraspanin pro-
teins and to the 
 
a
 
3 integrin subunit increases invasive 
potential of the MDA-MB-231 cells in the Matrigel-
penetration assay. A speciﬁc inhibitor of phosphoinosi-
tide 3-kinase (PI3K), LY294002, negated the effect of 
the monoclonal antibodies on the morphology of the 
Matrigel-embedded cells and on production of MMP-2. 
Interestingly, broad-spectrum inhibitors of protein ty-
rosine kinases (genistein) and protein tyrosine phos-
phatases (orthovanadate), and actin ﬁlament stabilizing 
compound (jasplakinolide), also block protrusive activ-
ity of the Matrigel-embedded cells but have no effect 
on the production of MMP-2. These results indicate 
that 
 
a
 
3
 
b
 
1–tetraspanin protein complexes may control 
invasive migration of tumor cells by using at least two 
PI3K-dependent signaling mechanisms: through rear-
rangement of the actin cytoskeleton and by modulating 
the MMP-2 production.
Key words: integrin • tetraspanin • invasion • matrix 
metalloproteinase • signaling
 
I
 
NVASIVENESS
 
, or migration through a three-dimen-
sional extracellular matrix (ECM)
 
1
 
 environment, is
a fundamental property of malignant cancer cells.
Tight control over the strength of cell–ECM interactions
efficiently coupled with ECM-degrading activity consti-
tutes a central point of the invasive process.
Degradation of surrounding ECM by tumor cells serves
two purposes during cell invasion: (a) to break a physical
barrier, and thereby facilitate cell movement through the
dense environment; and (b) to regulate cell–ECM interac-
tions by changing the conformation of ECM proteins.
Matrix metalloproteinases (MMPs) are a group of zinc-
dependent ECM-degrading enzymes that are thought to
play a critical role in tumor cell invasion (Stetler-Steven-
son et al., 1993; Coussens and Werb, 1996). It has been
shown that elevated levels of expression of different
MMPs are associated with a metastatic stage in progres-
sion of various types of tumors (Airola et al., 1997; Murray
et al., 1998; Sugiura et al., 1998; Talvensaari-Mattila et al.,
1998). Furthermore, when tested in animal model systems,
expression levels of MMP-2, MMP-7, and MMP-9 were
found to correlate with metastatic potential of tumor cells
(Montgomery et al., 1994; Hua and Muschel, 1996; Wilson
et al., 1997; Cockett et al., 1998; Hasegawa et al., 1998).
Thus, responsiveness of tumor cells to the extracellular
stimuli that affect production of MMPs may determine
their metastatic behavior.
Interestingly, one such stimulus is ECM itself. It has
been previously reported that cell–ECM interactions me-
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diated by adhesion receptors of the integrin family may
have a significant impact on production of MMPs by tu-
mor cells (Heino, 1996). In osteosarcoma cells, the 
 
a
 
2
 
b
 
1
integrin is a positive regulator of the expression of MMP-1
(Riikonen et al., 1995). Integrin-mediated adhesion to
laminin and antibody-induced clustering of 
 
a
 
3
 
b
 
1 integrin
enhanced the secretion of MMP-2 in rhabdomyosarcoma
and glioblastoma cells (Chintala et al., 1996; Kubota et al.,
1997). Likewise, production of MMP-2 during melanoma
cell invasion was modulated by 
 
a
 
v
 
b
 
3 and 
 
a
 
5
 
b
 
1 integrins
(Seftor et al., 1993). Signaling pathways that link activa-
tion of integrin receptors and production of MMPs in tu-
mor cells are poorly understood. In osteosarcoma cells,
wide range inhibitors of protein tyrosine kinases could
prevent upregulation of MMP-1 by collagen (Riikonen et
al., 1995). In ovarian cancer cells, both focal adhesion ki-
nase and Ras are required for production of MMP-9 in-
duced by fibronectin (Shibata et al., 1998).
Integrins also play a pivotal role in the regulation of a
rapid turnover of cell–ECM adhesion contacts and actin
cytoskeleton dynamics during invasive migration. A com-
plex network of integrin-mediated signaling pathways,
involving small Rho-family GTPases, phosphoinositide
3-kinase (PI3K), and nonreceptor tyrosine kinases of the
Src family, sets the basis for migratory behavior of tumor
cells (Keely et al., 1997; Shaw et al., 1997; Thomas and
Brugge, 1997). Interestingly, remodelling of actin cytoskel-
eton induced by ECM may be directly linked to activation
and regulation of MMP production (Tomasek et al., 1997;
Chintala et al., 1998). Although significant progress has
been made recently towards identifying key elements
within the invasion-related signaling network, relatively
little is known about the initial steps of the signaling pro-
cesses triggered by integrin receptors. Among the numer-
ous integrin-associated protein partners identified (Hem-
ler, 1998), only a few seem to have a direct relevance to
the invasive process. The receptor for urokinase type plas-
minogen activator interacts with various integrin receptors
and may have an important role in tethering ECM-degrad-
ing activity to the adhesion sites (Chapman, 1997). Focal
adhesion kinase, which is associated with the cytoplasmic
tail of various integrin 
 
b
 
 subunits and activated upon inte-
grin ligation, is thought to regulate structural organization
and turnover of adhesion complexes (Ilic et al., 1995;
Guan, 1997).
Tetraspanins, or TM4SF proteins, are a large group of
widely expressed cell surface transmembrane proteins,
some of which can form complexes with various integrins
(Hemler et al., 1996; Maecker et al., 1997). A number of
tetraspanins were described as tumor-specific antigens
(Szala et al., 1990; Marken et al., 1992; Jankowski et al.,
1994; Takagi et al., 1995), and recent evidence suggests
that the function of some TM4SF proteins may be particu-
larly relevant to tumor cell metastasis. For example, ec-
topic expression of CD9, CD63, or CD82 in tumor cells
suppressed their metastatic potential in animal model sys-
tems (Ikeyama et al., 1993; Dong et al., 1995; Radford et
al., 1995). Furthermore, elevated levels of expression of
CD9 and CD82 were linked to a higher survival rate for
various human cancers (Miyake et al., 1995; Adachi et al.,
1996). It was hypothesized that tetraspanins may be impli-
cated in the assembly of integrin-containing signaling com-
 
plexes, thus modulating the function of integrin receptors in
cell migration (Hemler et al., 1996; Berditchevski et al.,
1997b; Domanico et al., 1997; Maecker et al., 1997; Yáñez-
Mó et al., 1998; Yauch et al., 1998). In this study we ana-
lyzed invasive migration of mammary carcinoma cells
within the three-dimensional ECM environment and ex-
amined the involvement of tetraspanins in this process.
Our results indicate that 
 
a
 
3
 
b
 
1–tetraspanin protein com-
plexes play an important role in regulating protrusive ac-
tivity of the tumor cells and contribute to ECM-induced
production of MMP-2.
 
Materials and Methods
 
Reagents
 
Herbimycin B, sodium orthovanadate, genistein, cytochalasin B, and
aprotinin were purchased from Sigma Chemical Co. LY294002, ML7,
KT5720, bisindolylmaleimide I, and human recombinant tissue inhibitor
of metalloproteinases (TIMP)-2 were from Calbiochem. Jasplakinolide
was obtained from Cambridge Bioscience. A broad-range inhibitor of
MMPs, BB3103, was provided by British Biotech Pharmaceuticals Ltd.
Rat tail collagen, type I was purchased from Collaborative Biomedical
Products.
 
Antibodies and Cells
 
Antiintegrin mAbs used were: anti-
 
a
 
2, A2-IIE10 (Lee et al., 1995) and
A2-VIIC6 (Lee et al., 1995); anti-
 
a
 
3, P1B5 (Carter et al., 1990) and A3-
IIF5 (Weitzman et al., 1993); anti-
 
a
 
6, A6-BB (Tachibana et al., 1997);
anti-
 
b
 
1, clone P5D2 (provided by Dr. N. Hotchin, University of Birming-
ham, Birmingham, UK). Anti-TM4SF mAbs were: anti-CD9, C9-BB (Tach-
ibana et al., 1997); anti-CD63, 6H1 (Berditchevski et al., 1995); anti-CD81,
M38 (Imai and Yoshie, 1993); anti-CD82, M104 (Imai and Yoshie, 1993);
and anti-CD151, 5C11 (Berditchevski et al., 1997a). Other mAbs were:
antiemmprin, 8G6 and 7E7 (Berditchevski et al., 1997a); anti–MMP-9,
4H3; and anti–MMP-1, SE600 (British Biotech Pharmaceuticals, Ltd.).
Anti–MMP-2 polyclonal antibody, AB808, was from Chemicon Interna-
tional. Antiphosphotyrosine (pTyr) mAb, clone 4G10, was purchased
from Cambridge Bioscience. Anti–p85 PI3K mAb, clone U13, and anti-
 
a
 
6
mAb, clone GoH3, were purchased from Serotech. Various anti–c-Akt
mAbs were purchased from New England Biolab. The MDA-MB-231 hu-
man breast cancer cell line was purchased from American Type Culture
Collection and maintained in L-15 Leibovitz medium (Sigma Chemical
Co.) supplemented with 15% FCS. HT1080/zeo and HT1080/CD9 cells
(Berditchevski et al., 1996) were cultured in DMEM supplemented with
10% FCS.
 
Three-Dimensional Cell Culture and Time-Lapse
Video Recording
 
To study the cell behavior in the three-dimensional ECM environment,
the cells were embedded into Matrigel (Becton Dickinson) according to
the manufacturer’s recommendations. In brief, MDA-MB-231 cells were
detached from culture dishes and suspended in Matrigel solution at the fi-
nal concentration of 5 
 
3 
 
10
 
4
 
 cells/ml at 4
 
8
 
C. The cell suspension was ali-
quoted (250–300 
 
m
 
l) into a 24-well plate and left to solidify at 37
 
8
 
C for 30
min. The cells embedded into Matrigel were cultured in L-15 growth me-
dium with or without FCS. For time-lapse video recording, Matrigel-
embedded cells were cultured in the temperature controlled humidified
box mounted on the stage of the inverted microscope (Axiovert 25; Carl
Zeiss). Migration of MDA-MB-231 cells within Matrigel was recorded us-
ing the Hitachi CCD camera connected to the computer (model P5-233;
Gateway 2000) and the captured images were processed using the Image
PC software package (Scion Co.).
 
Immunofluorescence Staining of MDA-MB-231 Cells in 
Three-Dimensional Matrices
 
Cellular localization of integrins and tetraspanins on the surface of em-
bedded MDA-MB-231 cells was analyzed by indirect immunofluores-
cence staining. The three-dimensional cultures were fixed with 1% 
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paraformaldehyde/PBS for 20 min and washed three times with PBS for
1 h. The primary antibodies were applied to the cultures and incubated for
1 h at room temperature. After three 10-min washes in PBS, samples were
incubated for 1 h at room temperature with FITC-conjugated goat anti–
mouse antibody (Sigma Chemical Co.). After subsequent washes, the
samples were analyzed using a Zeiss Axioscop. The immunofluorescence
images were captured using the Coolview CCD camera (Photonic Sci-
ences) and subsequently processed for analysis by using the Openlab soft-
ware package (Improvision).
 
Cell Adhesion Assay
 
A standard static adhesion assay (30–35 min) was carried out as described
previously (Weitzman et al., 1993). When the effect of mAbs on adhesion
was studied, cells were preincubated with mAbs at 4
 
8
 
C for 30 min and
then aliquoted into 96-well plates precoated with various concentrations
of Matrigel.
 
In Vitro Invasion Assay
 
For the invasion assay, an upper surface of 8-
 
m
 
m framed polycarbonate
filters (NeuroProbe, Inc.), was coated at 17.5 
 
m
 
g/cm
 
2
 
 of Matrigel for 30
min at 37
 
8
 
C. The lower compartments of the 96-well chemotactic Boyden
chamber were filled with L-15 medium supplemented with 5% FCS.
MDA-MB-231 cells (4 
 
3
 
 10
 
4
 
) were suspended in serum-free L-15 media
containing 30 
 
m
 
g/ml of BSA (no treatment) or mAb at a similar concen-
tration. In the experiments using a mixture of anti-TM4SF antibodies, the
mAbs C9-BB, 6H1, and 5C11 were combined at a final concentration of
10 
 
m
 
g/ml each. Untreated and mAb-treated cells were incubated for 1 h at
37
 
8
 
C before they were applied to the upper compartment of the chamber
(chamber well). After incubation for 20 h at 37
 
8
 
C in 5% CO
 
2
 
 and 95% air,
the filters were fixed with methanol and stained with 1% crystal violet
(Sigma Chemical Co.). The cells from the upper surface of the filter were
wiped off, and the migrated cells were counted in five to eight randomly
selected microscopic fields (
 
3
 
1,200) for each chamber well. All experi-
ments were performed in triplicate.
 
Gelatin Zymography
 
Production of MMPs by MDA-MB-231, HT1080/zeo, and HT1080/CD9
cells was analyzed by gelatin zymography as described previously (Heus-
sen and Dowdle, 1980). Cells suspended in the complete media were
plated for 4 h on the 100-mm bacteriological dish precoated either with
ECM ligands or immobilized antibodies. After three washes with serum-
free L-15 media, cells were incubated in serum-free media for an addi-
tional 24 or 48 h before the conditioned media were collected for the anal-
ysis. The conditioned media were supplemented with Laemmli sample
buffer, and the loading volumes of each sample were subsequently ad-
justed according to the cell number. The samples were resolved in 9%
acrylamide SDS-PAGE containing 1 mg/ml gelatin. The gels were washed
three times with 2.5% Triton X-100 for 1 h, and incubated for 24 h at 37
 
8
 
C
in 50 mM Tris-HCl, pH 7.4, 10 mM CaCl
 
2
 
, 150 mM NaCl with 0.02%
NaN
 
3
 
. The lytic bands were visualized by Coomasie brilliant blue R250
staining. After staining, the gels were scanned using the GI6000 Gel densi-
tometer (Bio-Rad) and analyzed using the Molecular Analyst software
package (Bio-Rad).
 
Immunoprecipitation and PI3K Assay
 
Serum-starved MDA-MB-231 cells were plated on the immobilized mAbs
or ECM ligands in serum-free DMEM for 1 h. Cells were lysed for 3 h at
4
 
8
 
C in 1% Brij 98 buffer containing 20 mM Tris HCl, pH 7.4, 140 mM
NaCl, 10% glycerol, 1 mM Na
 
3
 
VO
 
4
 
, 1 mM NaF, 10 mM Na-pyrophos-
phate, 2 mM PMSF, 5 
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml leupeptin. Insoluble
material was pelleted at 13,000 rpm and the supernatants were precleared
overnight at 4
 
8
 
C with goat anti–mouse Ig antibody immobilized on aga-
rose beads (Sigma Chemical Co.). The precleared lysates were incubated
for 3 h with the appropriate mAb captured on the goat anti–mouse Ig an-
tibody immobilized on agarose beads. The immunoprecipitates were
washed once with the lysis buffer, then twice with a solution containing
0.1 M Tris HCl, pH 8.0, and 0.5 M LiCl, then once with a solution contain-
ing 10 mM Tris-HCl, pH 7.6, 1 mM EDTA, 0.1 M NaCl, and finally, once
with a kinase reaction buffer (40 mM Hepes, pH 7.4, 100 
 
m
 
M ATP, 5 mM
MgCl
 
2
 
). To initiate the kinase reaction, the beads were resuspended in
50 
 
m
 
l of the kinase buffer containing 30 
 
m
 
g of phosphatidylinositol (Sigma
 
Chemical Co.) and 5 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP. The reactions were terminated after
15 min with 60 
 
m
 
l 2 N HCl, and lipids were extracted with 160 
 
m
 
l of 1:1
(vol/vol) chloroform/methanol. The lipids were subsequently analyzed by
TLC (Yauch et al., 1998).
 
Immunoblotting
 
Serum-free growth medium, conditioned by MDA-MB-231 cells for 24 h,
was incubated with gelatin-conjugated Sepharose beads for 2 h at 4
 
8
 
C.
The beads were washed three times with 50 mM Tris HCl, pH 7.6, 150 mM
NaCl, 5 mM CaCl
 
2
 
, and the captured material was eluted from the beads
into Laemmli loading buffer at 95
 
8
 
C. Proteins were resolved in 10% SDS-
PAGE, transferred to the nitrocellulose membrane, and developed with
the specific anti-MMP antibody. Protein bands were visualized using
HRP-conjugated secondary antibodies and Enhanced Chemilumines-
cence Reagent (Amersham Pharmacia Biotech).
 
Results
 
In this study we investigated whether integrin–tetraspanin
protein complexes play a role in controlling invasive be-
havior of tumor cells. As a model system we used highly
invasive mammary epithelial cells, MDA-MB-231. In pre-
liminary experiments, we have established that MDA-
MB-231 cells express five TM4SF proteins (e.g., CD9,
CD63, CD81, CD82, and CD151) and each of them form
complexes with 
 
a
 
3
 
b
 
1 integrin (data not shown).
 
Migration of MDA-MB-231 Cells within Matrigel
 
Migration on planar surfaces coated with ECM proteins is
a widely used paradigm for analyzing tumor cell invasion.
Indeed, the data accumulated in these in vitro studies pro-
vided important insights into the molecular mechanisms
that may control invasive behavior of tumor cells. How-
ever, it became increasingly obvious that cellular re-
sponses may change when cells are placed within a three-
dimensional ECM environment (Boudreau and Bissell,
1998). Thus, we rationalized that migratory behavior of tu-
mor cells within a three-dimensional ECM could reflect an
invasion process more accurately and would allow better
understanding of the molecular mechanisms that control
invasive migration. In the course of this study we exam-
ined the behavior of MDA-MB-231 cells within artificial
EHS matrix (Matrigel). Time-lapse video microscopy has
shown that within the first 2–4 h after embedding into
Matrigel, characteristic short pseudopodial protrusions be-
gan to appear (Fig. 1). These protruding structures were
dynamic and typically retracted within 15–40 min. Al-
though they remained round, most cells had undergone
various types of motion, including wobbling, turning
around, and slow directional movement (Fig. 1, A–E). The
average rate of cellular migration within Matrigel was 3.44 
 
6
 
0.8 
 
m
 
M/h (calculated observing 19 cells in 12 separate ex-
periments). The random protrusive activity persisted over
48–72 h, with the protrusions becoming longer and more
stable at later times, and then decreased in number when
cells started to form round colonies. The cells exhibited
similar behavior when they were plated on top of polymer-
ized Matrigel (data not shown). These experiments have
demonstrated that migration through three-dimensional
ECM environment does not require cell spreading, but
may rely on short invasive protrusions developed by tu-
mor cells (see also below). 
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The 
 
a
 
3
 
b
 
1–Tetraspanin Protein Complexes Are 
Abundant at the Periphery of Thin Invasive Protrusions 
and Control Protrusive Activity of MDA-MB-231 Cells 
in Matrigel
 
We began investigating the role of 
 
a
 
3
 
b
 
1–tetraspanin pro-
tein complexes in invasive migration by examining their
distribution on the Matrigel-embedded MDA-MB-231
cells. In the initial experiments, we carried out whole-
mount immunofluorescence staining using nonpermeabi-
lized cells. When analyzing various focus planes, we found
that 
 
a
 
3
 
b
 
1 integrin and tetraspanins were concentrated
within distinctive large clusters covering the cell body and
at the tips of short thread-like protrusions (Fig. 2, A–D).
These microvilli-like protrusions extended from the main
cell body and from the pseudopodia (Fig. 2, G and H),
thus producing characteristic hairy images. In contrast,
clusters of 
 
a
 
2
 
b
 
1 integrin were visibly smaller and not de-
tected on the thread-like protrusions (Fig. 2, E and F).
Given their abundant presence at the tips of the mi-
crovilli-like cellular extensions, we addressed the question
as to whether the 
 
a
 
3
 
b
 
1–tetraspanin complexes have the
potential to affect protrusive activity of MDA-MB-231
Figure 1. Migration of MDA-MB-231 cells within Matrigel.
MDA-MB-231 cells were embedded into Matrigel and cultured
in a temperature-controlled humidified chamber for 24 h. (A–E)
A sequence of phase–contrast video images taken at 335 min (A),
620 min (B), 665 min (C), 690 min (D), and 705 min (E) after the
embedding. The arrowheads point to a highly dynamic invasive
protrusion. (F) A center point of the cell shown in A–E was cal-
culated and a trajectory of center point movement over 24 h was
plotted using the Analyze Particle module of the NIH image pro-
cessing program. An inset in B shows a digitally magnified image
of the invasive protrusion. Bar, 10 mm.
Figure 2. Localization of integrins and tetraspanins on the Matri-
gel-embedded cells. MDA-MB-231 cells were embedded into
Matrigel and cultured for 24 h in L-15 growth medium. The cul-
tures were fixed with 1% paraformaldehyde, and whole-mount
immunofluorescent staining was carried out using mAb P1B5 to
a3 integrin subunit (A, B, and G), mAb A2-VIIC6 to a2 integrin
subunit (E and F), and a mixture of antitetraspanin mAbs (C9-
BB, anti-CD9; 6H1, anti-CD63; M38, anti-CD81; 5C11, anti-
CD151) (C, D, and H). The staining was visualized using FITC-
conjugated goat anti–mouse Ig. Images at two focal planes (3.8
mm apart) were captured and processed using the OpenLab soft-
ware package. Arrowheads show localization of a3b1 integrin
and tetraspanins on short microvilli-like protrusions. Bar, 10 mm. 
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cells. Thus, we examined the effect of antitetraspanin
mAbs on the morphology of the cells embedded in Matri-
gel. These experiments were performed under serum-free
conditions to avoid growth factor interference. As in the
presence of serum, during the first 24 h after embedding,
the cells incubated without mAbs remained rounded, and
only 25–30% of them extended one or two short (0.25–0.5
size of the cell body diameter) pseudopodial protrusions
(Fig. 3 A). In contrast, 45–70% of the cells incubated with
mAbs to CD9, CD63, CD81, and CD151 developed long
thin extensions that often exceeded the cell body diameter
by 2–2.5-fold (Fig. 3, B–E). When analyzed using time-
lapse video microscopy, we found that in the presence of
antitetraspanin mAbs, protrusive activity of the cells was
not appreciably affected, whereas retraction of the inva-
sive protrusions was attenuated, thus leading to their ex-
tended elongation (Fig. 4). Notably, we observed that the
mAb-treated cells could use these elongated protrusions
to generate traction forces and facilitate directional move-
ments within Matrigel (Fig. 4). Importantly, the morpho-
genetic effect of the mAb to 
 
a
 
3 integrin subunit was com-
parable to that of antitetraspanin mAbs (Fig. 3 F). On the
other hand, mAbs to 
 
a
 
2 integrin subunit and emmprin, an
abundant cell surface protein that also form complexes
with 
 
a
 
3
 
b
 
1 integrin (Berditchevski et al., 1997a), had no ap-
preciable effect on cell morphology (Fig. 3, G and H, re-
spectively). Taken together, these results indicate that
 
a
 
3
 
b
 
1–tetraspanin complexes play an important role in
controlling protrusive activity of the MDA-MB-231 cells.
 
Effect of Pharmacological Inhibitors on the
mAb-induced Protrusive Activity of
MDA-MB-231 Cells
 
One explanation for the observed changes of cell mor-
phology is that the mAbs could directly affect adhesive
interactions between MDA-MB-231 cells and Matrigel.
Thus, we tested the effect of the antitetraspanin and anti-
integrin mAbs on attachment of the cells to various con-
centration of Matrigel. These experiments demonstrated
that mAbs to the 
 
a
 
3 integrin subunit or to tetraspanins
(tested separately or in various combinations) neither di-
minished nor increased adhesion of MDA-MB-231 cells to
Matrigel (Fig. 5). Interestingly, we found that the function
inhibitory mAb to the 
 
a
 
2 or 
 
a
 
6 integrin subunits also
failed to interfere with the adhesion of the cells to Matri-
gel. On the other hand, an inhibitory mAb to the 
 
b
 
1 in-
tegrin subunit almost completely blocked adhesion of
MDA-MB-231 cells to the substrate. While these results
clearly demonstrate that adhesive interactions of MDA-
MB-231 cells with Matrigel matrix involve various 
 
b
 
1 inte-
grins, they also argue against a direct modulation of cell
adhesiveness by the 
 
a
 
3
 
b
 
1–tetraspanin protein complexes.
We surmised that clustering with the antitetraspanin or
anti-
 
a
 
3 mAbs may trigger signaling events that induced
changes of morphology of the Matrigel-embedded cells.
To begin investigating which signaling pathway(s) is in-
volved in the mAb-mediated morphogenetic responses,
MDA-MB-231 cells (untreated or treated with the anti-
CD63 mAb) were cultured in Matrigel in the presence of
various pharmacological inhibitors. The results of these
experiments are shown in Fig. 6. Orthovanadate and
Figure 3. Antitetraspanin mAbs induce cellular protrusions on
the Matrigel-embedded MDA-MB-231 cells. MDA-MB-231 cells
were treated for 30 min at room temperature with 25 mg/ml of ei-
ther BSA (A) or purified mAbs: C9BB, anti-CD9 (B); 6H1, anti-
CD63 (C); M38, anti-CD81 (D); 5C11, anti-CD151 (E); A3-IIF5,
anti-a3 integrin subunit (F); A2-IIE10, anti-a2 integrin subunit
(G); 7E7, antiemmprin (H). The cells were embedded into Matri-
gel and cultured under serum-free conditions for 24 h. Quantita-
tive data on the effect of the mAbs are shown in the table. Per-
centage of cells that developed protrusions was calculated in five
randomly selected microscopic fields. A cell was scored positive
(e.g., cell with the protrusions) if it had at least one protrusion
with length equal or exceeding the diameter of the cell body. All
experiments were performed in triplicate. Bar, 10 mm.The Journal of Cell Biology, Volume 146, 1999 1380
genistein inhibited protrusive activity of both untreated
and mAb-treated cells, suggesting that the basal and anti-
body-induced protrusive activities involve functions of ty-
rosine phosphatase(s) and protein tyrosine kinase(s) (Fig.
6, G and H). In agreement with this notion, herbimycin,
another tyrosine kinase inhibitor, could mimic the mor-
phogenetic effect of the mAb (Fig. 6, B and E). Notably, a
specific inhibitor of PI3K, LY294002, inhibited only the
mAb-mediated morphogenetic response and did not affect
the basal protrusive activity of MDA-MB-231 cells (Fig. 6
I). In contrast, inhibitors of myosin light chain kinase
(ML7), protein kinase C (bisindolylmaleimide I), and
cAMP-dependent protein kinase (KT5720) had no appre-
ciable effects on the morphology of the Matrigel-embed-
ded cells (Fig. 6, K and L, and data not shown, respec-
tively). We also analyzed the effect of the drugs that affect
the actin cytoskeleton. Interestingly, we found that jas-
plakinolide, a macrocyclic peptide that induces actin poly-
merization (Sheikh et al., 1997), negated the effect of the
antitetraspanin mAb on cell morphology (Fig. 6 J). Con-
versely, cytochalasin B, which destabilizes actin filaments,
induced long protrusions even in the absence of the anti-
tetraspanin mAb (Fig. 6 C). Collectively, these results sug-
gest that the elongation of the invasive protrusions involve
activities of various classes of signaling enzymes (e.g., ty-
rosine kinases, tyrosine phosphatases, PI3K) and may be
linked to destabilization of the actin cytoskeleton.
Effect of Antiintegrin and Anti-TM4SF Protein 
Antibodies on Production of MMPs
We hypothesized that MMPs, a group of ECM-degrading
enzymes, may play an important role in controlling cellu-
lar behavior within Matrigel. Indeed, both basal and mAb-
induced protrusive activities of MDA-MB-231 cells were
completely abolished when the cells were cultured in the
presence of BB 3103, a wide-range MMP inhibitor (Fig. 7).
On the other hand, aprotinin, a common inhibitor of
serine proteases, caused only z25% inhibition of the
mAb-induced protrusive activities (Fig. 7). Next, we ad-
dressed the question whether or not a3b1–tetraspanin
complexes may be involved in the regulation of MMP pro-
duction. When grown on tissue culture plastic MDA-MB-
231 cells secrete two major gelatinolytic activities of 92
and 56 kD (Fig. 8 A, lane a). In addition, we consistently
detected a weaker gelatinolytic band of 72 kD. Western
blotting analysis carried out with MMP-specific antibody
has shown that 92-, 72-, and 56-kD proteins corresponded
to MMP-9, MMP-2, and MMP-1, respectively (Fig. 8 A,
lanes b–d). To examine whether clustering of the a3b1–
tetraspanin complexes with mAbs can affect production of
MMPs, MDA-MB-231 cells spread on tissue culture plas-
tic were incubated with anti-a3 or various antitetraspanin
mAbs for 48 h and the samples of conditioned media were
analyzed by gelatin zymography. As illustrated in Fig. 8 B,
treatment with anti-a3 and all four tested antitetraspanin
mAbs enhanced the production of the latent form of
MMP-2 by 2–15-fold. Notably, this treatment did not af-
fect production of MMP-9 or MMP-1 (Fig. 8 B, and data
not shown, respectively). In the control experiments, anti-
a2 or antiemmprin mAbs did not alter the amounts of
MMP-2 and MMP-9 secreted by the MDA-MB-231 cells.
Likewise, a specific increase in production of MMP-2 was
observed when the cells were plated on the immobilized
anti-a3 and antitetraspanin mAbs (Fig. 8 C). Interestingly,
we have noticed that the efficacy of the stimulatory signals
is dependent on presentation of the particular antitet-
raspanin mAb. Indeed, clustering with soluble anti-CD81
and anti-CD151 mAbs caused only a modest increase in
production of MMP-2 when compared with anti-CD9 and
Figure 4. Effect of the anti-CD151 mAb on morphology and migration of MDA-MB-231 cells in Matrigel. MDA-MB-231 cells were in-
cubated with the anti-CD151 mAb (as described in the legend to Fig. 3), embedded into Matrigel, and cultured in a temperature-con-
trolled humidified chamber for 24 h. (A–E) A sequence of phase–contrast video images taken at 5 min (A), 190 min (B), 305 min (C),
495 min (D), and 895 min (E) after the embedding. (F) A digital overlay of A and E showing contours of the cell in the beginning (white
dashed line) and at the end (black solid line) of the recording. Arrow indicates direction of the cell body translocation. Bar, 10 mm.Sugiura and Berditchevski a3b1–Tetraspanin Complexes in Cell Invasion 1381
anti-CD63 mAbs (Fig. 8 B, compare lanes e and g with
lanes d and f). On the other hand, the stimulation induced
by the immobilized mAbs was comparable for all four tet-
raspanins (Fig. 8 C, lanes b–f). Not only do these data sug-
Figure 5. Antitetraspanin and antiintegrin mAbs do not influ-
ence adhesion of the MDA-MB-231 cell to Matrigel. BCECF-
AM–labeled MDA-MB-231 cells were preincubated with antiin-
tegrin mAbs (25 mg/ml) and tested for adhesion to a 96-well mi-
crotiter plate coated with Matrigel as described in Materials and
Methods. The mAbs used were: P5D2, anti-b1; GOH3, anti-a6;
A2-IIE10, anti-a2; A3-IIF5, anti-a3; C9BB, anti-CD9; 6H1, anti-
CD63; 5C11, anti-CD151; and 7E7, antiemmprin. The results are
presented as percentage of attached cells.
Figure 6. Effect of pharmacological inhibitors on the mAb-
induced protrusive activity of MDA-MB-231 cells. MDA-MB-
231 cells were treated with BSA (A–C) or 6H1, anti-CD63 mAb
(D–L) as described in the legend to Fig. 3. The cells were cul-
tured for 24 h within Matrigel in the media containing various
pharmacological inhibitors. A and D, no inhibitors; B and E, her-
bimycin B (100 ng/ml); C and F, cytochalasin B (25 mg/ml); G,
orthovanadate (100 mM); H, genistein (10 mg/ml); I, LY294002
(10 mM); J, jasplakinolide (500 nM); K, ML7 (1 mM); L, bisin-
dolylmaleimide I (20 nM). Shown are representative cells. Quan-
titative data on the effect of the inhibitors are shown in the table.
The percentage of cells that developed protrusions was calcu-
lated in five randomly selected microscopic fields. The cell was
scored positive (e.g., cell with the protrusions) if it had at least
one protrusion with length equal or exceeding the diameter of
the cell body. All experiments were performed in triplicate. Bar,
10 mm.The Journal of Cell Biology, Volume 146, 1999 1382
gest that the postclustering events that follow the binding
of soluble mAbs to the cells (for example, endocytosis
and/or recycling of the a3b1–tetraspanin protein com-
plexes) are regulated in the mAb-specific manner, but
they also point to another level of control over the cellular
response to the clustering of the complexes.
To obtain direct evidence that tetraspanins are involved
in the adhesion-dependent production of MMP-2, we ex-
amined gelatinolytic activities present in culture media
conditioned by HT1080/zeo and HT1080/CD9 cells. The
HT1080/CD9 line has been established by expressing hu-
man CD9 cDNA in HT1080, the human fibrosarcoma cell
line, whereas HT1080/zeo was developed as a control
drug-resistant cell line (see Materials and Methods for de-
tails). Both cell lines expressed similar levels of b1 inte-
grins and were comparable in their ability to attach to var-
ious ECM ligands (data not shown). When plated on
collagen or laminin 5–containing ECM, both cell lines se-
crete comparable amounts of MMP-9 (Fig. 9, lanes a–d).
Strikingly, the amount of MMP-2 secreted by the HT1080/
CD9 cells plated on laminin 5–containing ECM was signif-
icantly higher (approximately fourfold) than that secreted
by the HT1080/zeo cells (Fig. 9, lanes b and d). On the
other hand, growth media conditioned by the cells plated
on collagen contained similar amounts of MMP-2 (Fig. 9,
lanes a and c). Given the fact that attachment of the
HT1080 cells to laminin 5–containing ECM is mediated by
a3b1 integrin (Wayner et al., 1993), these results provide
strong support for the idea that a3b1–tetraspanin protein
complexes (and the a3b1–CD9 complex in particular) may
be involved in the ECM-induced production of MMP-2.
Next, we carried out two sets of experiments to address
the question of whether the effect of the mAbs on the
morphology of the Matrigel-embedded cells is related to
the increased production of MMP-2. First, MDA-MB-231
cells were cultured in Matrigel in the presence of both
anti-CD63 mAb and TIMP-2, a potent inhibitor of MMP-2.
Figure 7. Effect of the inhibitors
of matrix proteinases on the
mAb-induced protrusive activ-
ity of MDA-MB-231 cells. The
cells were treated with mAb 6H1
and embedded into Matrigel as
described in the legend to Fig. 3.
Embedded cells were cultured
for 24 h in serum-free media
supplemented with BSA plus ve-
hicle (None), 25 mg/ml mAb
6H1 (6H1), 25 mg/ml mAb 6H1
plus 10 mM MMP inhibitor BB
3103 (6H11BB), 25 mg/ml
mAb 6H1 plus 0.75 mg/ml re-
combinant human TIMP-2
(6H11TIMP), and 25 mg/ml
mAb 6H1 plus 100 mg/ml aproti-
nin (6H11Apr). The percent-
age of cells that developed protrusions was calculated in five ran-
domly selected microscopic fields. The cell was scored positive
(e.g., cell with the protrusions) if it had at least one protrusion
with length equal or exceeding the diameter of the cell body. All
experiments were performed in triplicate.
Figure 8. Activation of the a3b1–tetraspanin protein complexes
with mAbs induces production of MMP-2. (A) MMP profile of
MDA-MB-231 cells. Samples of culture media conditioned by
MDA-MB-231 cells were resolved in 10% PAGE and analyzed
by a gelatin zymography (lane a) or by Western blotting with
mouse mAb 4H3, anti–MMP-9 (lane b), rabbit polyclonal anti-
body 808, anti–MMP-2 (lane c), and rabbit polyclonal antibody
SE600, anti–MMP-1 (lane d). (B) MDA-MB-231 cells were
plated on a 24-well plate in serum-containing growth media for 8 h.
After washes with PBS, the cells were incubated for 48 h in se-
rum-free media supplemented with 25 mg/ml BSA (control sam-
ple, lane a); mAb A2-VIIC6, anti-a2 integrin (lane b); mAb A3-
IIF5, anti-a3 integrin (lane c); mAb 6H1, anti-CD63 (lane d);
mAb M38, anti-CD81 (lane e); mAb C9-BB, anti-CD9 (lane f);
mAb 5C11, anti-CD151 (lane g); and mAb 7E7, antiemmprin
(lane h). Conditioned media were analyzed by gelatin zymogra-
phy as described in Materials and Methods. Gelatinolytic activi-
ties of the samples were quantified by scanning densitometry us-
ing the Molecular Analyst software package, and the data are
presented as percentage relative to a control sample. (C) MDA-
MB-231 cells were plated on immobilized mAbs in serum-con-
taining growth media for 4 h. After washes with PBS, the cells
were incubated for 24 h in serum-free media before the samples
of the conditioned media were analyzed by gelatin zymography.
Gelatinolytic activities of the samples were quantified as above,
and the data are presented as percentage relative to a sample col-
lected from the cells plated on antiemmprin mAb. The immobi-
lized mAbs were: P1B5, anti-a3 (lane a); C9-BB, anti-CD9 (lane
b); 6H1, anti-CD63 (lane c); M38, anti-CD81 (lane d); M104,
anti-CD82 (lane e); 5C11, anti-CD151 (lane f); and 7E7, anti-
emmprin (lane g). (B and C) White columns represent MMP-9,
and black columns represent MMP-2.Sugiura and Berditchevski a3b1–Tetraspanin Complexes in Cell Invasion 1383
and changes of cell morphology could affect invasiveness
of MDA-MB-231 cells, we performed the Matrigel pene-
tration assay. As shown in Fig. 11 A, continuous presence
of various antitetraspanin mAbs during the time of the as-
say (tested separately or in combinations) increased inva-
siveness of MDA-MB-231 cells 1.5–3.5-fold. Similarly, the
mAb to a3 integrin subunit also facilitated cell invasion
through Matrigel. Interestingly, we found that the inhibi-
tory mAb to a2 integrin subunit also increased invasive-
ness of the MDA-MB-231 cells (up to 1.6-fold). In the con-
trol experiments, mAbs to a6 integrin subunit or to
emmprin had no effect on cell invasion (Fig. 11 A). Next
we investigated the effect of pharmacological inhibitors on
invasiveness of MDA-MB-231 cells. As illustrated in Fig.
11 B, inhibitors to PI3K, myosin light chain kinase, and
one of the protein tyrosine kinase inhibitors, genistein, ef-
ficiently blocked cellular invasion induced by the antitet-
raspanin mAb, with only a minimal effect on the basal
level of invasion. Similarly, treatment with jasplakinolide
specifically negated the effect of the mAb on invasion of
MDA-MB-231 cells. On the other hand, orthovanadate,
cytochalasin B, and to a certain extent protein kinase C in-
hibitor were effective in blocking both basal and mAb-
induced cellular invasion (Fig. 11 B). Interestingly, herbi-
mycin, a more selective inhibitor of tyrosine kinases, had
no effect on the mAb-induced invasion but facilitated
basal invasiveness of the MDA-MB-231 cells. Taken to-
gether, these results demonstrate that the invasive process
involves multiple signaling proteins, and there is only a
partial correlation between the ability of MDA-MB-231
cells to develop invasive protrusions and their overall in-
vasive potential. Finally, we investigated the contribution
of MMPs in cellular invasion through Matrigel. We found
that both broad-range (BB 3103) and more selective
(TIMP-2) inhibitors of MMPs decreased invasiveness of
the MDA-MB-231 cells (Fig. 11 C).
As shown in Fig. 7, TIMP-2 only partially negated the
mAb-induced protrusive activity of the MDA-MB-231
cells. Second, we analyzed the effect of pharmacological
inhibitors on the mAb-induced production of MMP-2.
These experiments were carried out with MDA-MB-231
cells plated on the immobilized antitetraspanin mAb. Pre-
liminary experiments have demonstrated that the pres-
ence of pharmacological inhibitors during the time of the
experiment had no significant effect on the morphology or
viability of the cells attached to the immobilized antitet-
raspanin mAbs. However, we decided against applying the
inhibitors to the mAb-treated cells grown on the uncoated
glass coverslips (as in the experiment shown in Fig. 8 B),
since some of them induced dramatic changes of cell mor-
phology and might, therefore, affect the MMP production
in a nonspecific fashion. The MDA-MB-231 cells were
seeded on immobilized anti-CD151 mAb, the strongest
stimulus of MMP-2 production (Fig. 8 C, lane f), and the
effect of the pharmacological inhibitors was analyzed 24 h
after the plating. Of the various inhibitors tested, we found
that only LY294002 (inhibitor of PI3K) had a negative ef-
fect on the MMP-2 production induced by the antitet-
raspanin mAb (Fig. 10, lane g). Thus, we concluded that
the PI3K-dependent signaling pathway makes an essential
contribution in the production of MMP-2 triggered by the
a3b1–tetraspanin complexes. However, increased produc-
tion of MMP-2 by itself may not be sufficient to facilitate
cell protrusive activity within three-dimensional ECM, as
orthovanadate, a potent inhibitor of the protrusive activity
(Fig. 6 G), had no effect on MMP-2 production.
A Role of the a3b1–Tetraspanin Protein Complexes in 
Tumor Cell Invasion
To analyze whether antibody-induced production of MMP-2
Figure 9. The a3b1–tet-
raspanin protein complexes
are involved in ECM-regu-
lated production of MMP-2.
HT1080/zeo and HT1080/
CD9 cells were plated on im-
mobilized collagen type I (10
mg/ml, col I; lanes a and c), or
on laminin 5–containing ma-
trix, (LN-5; lanes b and d) for
4 h in serum-containing
growth media. After washes
with PBS, the cells were in-
cubated for 24 h in serum-
free media before the sam-
ples of the conditioned
media were analyzed by
gelatin zymography. Gela-
tinolytic activities of the sam-
ples were quantified as de-
scribed in the legend to Fig.
8, and the data are presented
in arbitrary densitometric
units.
Figure 10. Effect of the
pharmacological inhibitors
on the mAb-induced produc-
tion of MMP-2. MDA-MB-
231 cells were plated on
immobilized mAb 8G6, anti-
emmprin (lane a), and mAb
5C11, anti-CD151 (lanes b–g),
as described in the legend to
Fig. 8 C. The cells were incu-
bated for 24 h in serum-free
media supplemented with
various inhibitors before the
samples of the conditioned
media were analyzed by gela-
tin zymography. The inhibi-
tors examined were: ortho-
vanadate (100 mM, OR; lane
c); herbimycin B (100 ng/ml,
HB; lane d); KT5720 (100
nM, KT; lane e); bisindolyl-
maleimide I (20 nM, BIS; lane f); LY294002 (10 mM, LY; lane g).
Gelatinolytic activities of the samples were quantified as de-
scribed in the legend to Fig. 8, and the data are presented as per-
centages relative to a sample collected from the cells plated on
anti-CD151 mAb in the inhibitor-free media (lane b).The Journal of Cell Biology, Volume 146, 1999 1384
The Role of the a3b1–Tetraspanin Protein Complexes 
in Activation of PI3K
Given a notable consistency of LY294002 inhibiting both
morphological and biochemical consequences of the mAb
clustering, we wanted to investigate whether there is a di-
rect link between activation of the a3b1–tetraspanin com-
plexes and signaling pathways involving PI3K. To this end
two sets of experiments were carried out. First, we exam-
ined whether or not plating of MDA-MB-231 cells on the
mAbs facilitated an interaction of PI3K with tyrosine
phosphorylated cellular proteins. Lipid kinase assays per-
formed on the anti-pTyr immunoprecipitates have shown
that the activities of the associated enzyme in cells plated
on different substrates (including various mAbs and ECM
proteins) were unchanged relative to a control sample
(e.g., cells kept in suspension) (Fig. 12, A–C). Second, we
assessed phosphorylation levels of c-Akt, a serine/threo-
nine kinase whose phosphorylation (and activation) is reg-
ulated by PI3K (Downward, 1998). We found that plating
of MDA-MB-231 cells on various antitetraspanin and par-
ticular anti-a3 mAbs induced a small (z1.8–4-fold, in 3
separate experiments) but reproducible increase in the
phosphorylation levels of c-Akt (Fig. 12 D, upper panel,
lanes c–e and lane b, respectively, and Fig. 12 E). On the
other hand, c-Akt phosphorylation level in the cells at-
tached to the antiemmprin mAb was comparable to that
found in the control sample (e.g., cells kept in suspension)
(Fig. 12 D, upper panel, lanes f and a, respectively). Al-
though activation of c-Akt may not be directly related to
cell invasion (Shaw et al., 1997) or induction of cellular
protrusions within Matrigel, these results clearly indicate
Figure 11. A role of the a3b1–tetraspanin protein complexes in
invasion of MDA-MB-231 cells. (A) Effect of the antitetraspanin
and antiintegrin mAbs on invasion of MDA-MB-231 cells. The
MDA-MB-231 cells were preincubated with 30 mg/ml of BSA or
purified mAbs, and subsequently applied to the upper compart-
ment of the 96-well chemotactic migration chamber. Cells were
allowed to migrate towards the serum-containing media through
the Matrigel-coated 8-mM polycarbonate filter for 20 h. Cells on
the bottom side of the filter were counted on six to eight ran-
domly selected microscopic fields. The data are presented as per-
centage relative to a control (BSA-containing) sample. The
mAbs used were: A2-IIE10, anti-a2 integrin; A3-IIF5, anti-a3 in-
tegrin; A6-BB, anti-a6 integrin; 6H1, anti-CD63; M38, anti-
CD81; C9-BB, anti-CD9; 5C11, anti-CD151; and 7E7, antiemm-
prin. (B) Effect of pharmacological inhibitors on invasion of
MDA-MB-231 cells induced by the anti-CD151 mAb. The
MDA-MB-231 cells were pretreated with the anti-CD151 mAb
as in A in the presence of various pharmacological inhibitors.
Cellular invasion through Matrigel was analyzed as described in
A. OR, orthovanadate (100 mM); HB, herbimycin B (100 ng/ml);
GEN, genistein (10 mg/ml); KT, KT5720 (100 nM); BIS, bisin-
dolylmaleimide I (20 nM); ML, ML7 (1 mM); LY, LY294002
(10 mM); CYTO, cytochalasin B (25 mg/ml); JAS, jasplakinolide
(500 nM). (C) Effect of MMP inhibitors on invasion of MDA-
MB-231 cells induced by the antitetraspanin and anti-a3 mAbs.
The MDA-MB-231 cells were pretreated with the mAb as in A
either in the absence (white bars) or in the presence of MMP in-
hibitors: BB 3103, 10 mM MMP, black bars; recombinant human
TIMP-2, 0.75 mg/ml, hatched bars. Cellular invasion through
Matrigel was analyzed as described in A. All of the above experi-
ments were carried out in triplicates (e.g., three parallels for each
treatment). All of the experiments were repeated at least three
times. Error bars represent standard deviations of the ratios cal-
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the a3b1–tetraspanin protein complexes can modulate sig-
naling pathway involving PI3K.
Discussion
Penetration through the basement membrane is an impor-
tant step during tumor dissemination. To gain an insight
into cellular and molecular mechanisms that control this
process we examined invasive behavior of tumor cells in
response to Matrigel, a widely used mimic of the basement
membrane. Numerous earlier studies have provided a de-
tailed morphological analysis of tumor cells migrating
across planar surfaces, and uncovered a number of signal-
ing pathways controlling cell motility. A critical novel as-
pect of our study is the choice to use three-dimensional
Matrigel to analyze specifically invasive migration. By cul-
turing cells within a three-dimensional ECM environment,
we were aiming to observe cellular responses that would
more accurately reflect invasive processes occurring in
vivo. Our data clearly indicate that significant differences
exist between planar and three-dimensional migration.
Migration of MDA-MB-231 cells on absorbed Matrigel
could be described by a well-defined three-step extension–
retraction model: extension of lamellipodial protrusions ®
generation of traction forces, jerky cell body translocation
® retraction of the trailing edge (Sugiura, T., and F. Ber-
ditchevski, unpublished results). In contrast, cells embed-
ded in or plated on top of Matrigel remain rounded and
generate highly dynamic short pseudopodial extensions
that may play a major part in governing limited ability for
invasive movement (mainly, wobbling, turning around,
and slow directional movement). The evidence presented
in this report suggests that a3b1–tetraspanin protein com-
plexes could make two important contributions into the
invasive process. First, the a3b1–tetraspanin protein com-
plexes can control elongation of invading pseudopodia.
Second,  a3b1–tetraspanin protein complexes are involved
in the production of MMP-2, a member of the MMP fam-
ily that is associated with the invasive phenotype of tumor
cells both in vivo and in vitro.
Rapid retraction of the invasive pseudopodia within
three-dimensional ECM environment, saturated with po-
tential integrin-binding sites, implies that the signaling
pathways triggered within extending protrusions are di-
Figure 12. A role of a3b1–tet-
raspanin complexes in activation
of PI3K. (A and B) Serum-
starved MDA-MB-231 cells
were plated on the immobilized
mAbs or ECM ligands (A, lane
f, collagen I; and lane g, laminin
5–containing ECM), or kept in
suspension (SUS) for 1 h. The
cells were lysed and the lysates
were subjected to immunopre-
cipitation (IP) with anti-pTyr
mAb (4G10), anti-p85 mAb
(U13), or control mAb (187.1).
The coprecipitated material was
analyzed for PI3K activity using
an in vitro kinase assay as de-
scribed in Materials and Meth-
ods. The positions of 32P-phos-
phatidylinositol are indicated. The
mAbs used were: A2-VIIC6,
anti-a2 integrin (A, lane d);
P1B5, anti-a3 integrin (A, lane
e); C9-BB, anti-CD9 (B, lane d);
6H1, anti-CD63 (B, lane e);
M38, anti-CD81 (B, lane f); and
8G6, antiemmprin (B, lane g).
(C) The amounts of 32P-PI in the
samples were quantified using a
PhosphorImager (Molecular Dy-
namics). (D) Serum-starved
MDA-MB-231 cells were plated
on immobilized mAbs as above.
The cellular lysates were pre-
pared and the proteins were re-
solved in 10% SDS-PAGE.
Phosphorylation of c-Akt in the
lysates was analyzed by Western
blotting with a mixture of anti–phospho-specific (308Thr and 473Ser) c-Akt antibodies (upper panel). The total amounts of c-Akt in
the lysates were visualized using control anti–c-Akt antibody (lower panel). (E) Densitometric measurements of the experiment shown
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rected against generating strong cell–ECM interactions
along the protrusion length. Given the effect of the anti-
tetraspanin mAbs on the morphology of the Matrigel-
embedded cells, we hypothesize that the function of the
a3b1–tetraspanin protein complexes may be linked to sta-
bilization of the invasive protrusions. Furthermore, our
data indicate that the a3b1 integrin in complexes with tet-
raspanins plays a modulatory/signaling role in this process.
Although it is theoretically possible that the morphoge-
netic effect of the mAbs is caused by direct modulation of
adhesive capacity of the a3b1 integrin, two lines of evi-
dence argue against this notion. First, treatment of MDA-
MB-231 cells with anti-TM4SF mAbs did not influence ad-
hesion of the cells to Matrigel (Fig. 5) or to any other
ECM ligands that were tested in a short-term adhesion as-
say (Berditchevski, F.B., unpublished results). Second, the
a3b1–tetraspanin complexes were clustered at the tips of
short, thread-like protrusions that resembled microvilli,
distinct morphological structures that are thought to medi-
ate transient rather than stable adhesive interactions
(Vestweber and Blanks, 1999). Indeed, the a3b1–tetraspa-
nin clusters were devoid of vinculin (Sugiura, T., unpub-
lished results), a cytoskeletal protein associated with focal
complexes and focal adhesions (both are stable adhesion
complexes) but known to be excluded from microvilli
(Carpen et al., 1992; Amieva and Furthmayr, 1995). The
fact that jasplakinolide blocks the mAb-induced exten-
sion of protrusions whereas cytochalasin B induces their
formation even in the absence of the mAbs suggests that
the actin cytoskeleton is the ultimate target for the signals
triggered by the a3b1–tetraspanin complexes. Although a
particular intermediary component that may be in-
volved in the a3b1–tetraspanin-induced reorganiza-
tion remains unknown, actin-binding proteins of the
ezrin/radixin/moesin (ERM) family may be among the
potential candidates. In this regard, it has been reported
that the ectopic expression of the truncated form of ezrin
and moesin could destabilize cortical cytoskeleton and in-
duce formation of long filopodia-like extensions (Martin
et al., 1995; Amieva et al., 1999). Furthermore, thrombin-
induced phosphorylation of moesin on threonine 558 in
platelets, a modification that potentiates its binding to
F-actin, closely correlated with the formation of long
filopodial protrusions (Nakamura et al., 1995).
Numerous earlier studies have shown that the dynamics
of actin cytoskeleton can be controlled at various levels,
with different tyrosine kinases, tyrosine phosphatases, and
PI3K being intimately involved in this process (Schmidt
and Hall, 1998). Which signaling pathways are utilized by
the a3b1–tetraspanin protein complexes to manipulate ac-
tin cytoskeleton in the MDA-MB-231 cells? As a part of
the current study, we specifically addressed the question as
to whether or not activity of the a3b1–tetraspanin protein
complexes is linked to the PI3K signaling pathways. Our
data clearly indicate that this link is possible. First, we
found that LY29004, a specific inhibitor of PI3K, has com-
pletely abolished a morphogenetic effect of the mAbs and
attenuated mAb-induced invasiveness of the MDA-MB-
231 cells. Second, we observed that clustering of the a3b1–
integrin protein complexes stimulates phosphorylation of
c-Akt, a process that is tightly dependent on the activity of
PI3K (Downward, 1998). Although by itself phosphoryla-
tion of c-Akt may not be directly related to the rearrange-
ment of the actin cytoskeleton, these data illustrate a
functional connection between the a3b1–integrin protein
complexes and PI3K-dependent signaling. Earlier studies
have shown that PI3K activity can be stimulated by cell
adhesion to ECM (King et al., 1997). Furthermore, at least
two integrin receptors (e.g., a6b4 and aIIBb3) were spe-
cifically implicated in activation of PI3K-dependent sig-
naling in carcinoma cells and in platelets (Shaw et al.,
1997; Banfic et al., 1998). However, the proximal events
linking the ligation of these integrins to the PI3K signaling
pathways remain unknown. Thus, our data not only indi-
cate that another integrin, a3b1, is involved in the PI3K-
dependent signaling, but also point to a specific type of the
integrin accessory proteins that is required for this process
(see also below). Theoretically, integrins can affect the
PI3K-dependent signaling either directly (by modulating
enzymatic activity of PI3K) or indirectly (by regulating ac-
tivities and/or compartmentalization of other cellular pro-
teins involved in the PI3K signaling, e.g., other phosphati-
dylinositide kinases, phosphatidylinositide phosphatases,
cytoskeletal proteins). In turn, activation of PI3K may be
linked to tyrosine phosphorylation of cellular proteins
(Shaw et al., 1997), which either directly (through Src ho-
mology 2 [SH2] domain of p85 subunit of the class I PI3K)
or indirectly (through Ras-dependent activation of p110
subunit of PI3K) recruit and activate the enzyme (Rod-
riguez-Viciana et al., 1996; Fruman et al., 1998). The fact
that activity of the PI3K coimmunoprecipitated with pTyr-
containing cellular proteins was not affected in cells at-
tached to the antitetraspanin mAbs argues against the
former possibility, and suggests alternative mechanisms.
For example, it is possible that the function of a3b1–tet-
raspanin protein complexes is linked to the activation of
the class II or class III PI3Ks, the enzymes that are regu-
lated in a different fashion from well-characterized mecha-
nisms of activation of the class I PI3Ks. A similar pathway
has been shown to operate in platelets after the activation
of the aIIBb3 integrin (Banfic et al., 1998). Alternatively,
it is possible that the complexes can influence the PI3K-
dependent signaling without directly affecting the activity
of the enzyme. For example, it is feasible that the a3b1–
tetraspanin protein complexes can regulate local concen-
tration of phophatidylinositol (PtdIns)-4-P, a potential
substrate for PI3K, using associated phosphatidylinositol
4-kinase (Berditchevski et al., 1997b; Yauch et al., 1998).
This may subsequently increase production of PtdIns-3,4-
P2. Not only does this lipid specifically target various
cellular proteins whose function may be linked to actin cy-
toskeleton (e.g., gelsolin, profilin, some isoforms of pro-
tein kinase C [Martin, 1998]), but when further converted
to PtdIns-3,4,5-P3, it may facilitate additional recruitment
(through the SH2 domain of its regulatory subunit) of
PI3K and subsequent allosterical activation of the enzyme
(Fruman et al., 1998). Conversely, we cannot exclude a
possibility that a3b1–tetraspanin protein complexes mod-
ulate activity of phosphoinositide phosphatases (e.g., SH2
domain–containing inositol 59-phosphatase, PTEN), thus
affecting local concentrations of D-3 phosphoinositides
available for binding to their protein targets (including
c-Akt). Distinguishing between these various possibilities
represents an important challenge for future studies.Sugiura and Berditchevski a3b1–Tetraspanin Complexes in Cell Invasion 1387
An important aspect for consideration in invasive mi-
gration is the balance between the protruding forces gen-
erated by the cell and the surrounding extracellular ma-
trix, a mechanical barrier that confronts them. Although
different groups of ECM-degrading enzymes may be po-
tentially involved, our data indicate that MMPs have a ma-
jor role in both supporting protrusive activity and invasive
migration of MDA-MB-231 cells. The involvement of inte-
grins in MMP-dependent degradation of ECM occurs at
various levels, including regulation of production of the
enzymes (see Introduction), their activation (Stanton et
al., 1998), and site-specific targeting (Brooks et al., 1996).
Here we have shown that signaling through the a3b1 inte-
grin, but not through a2b1 or a6b4 integrins, specifically
regulates production of MMP-2. These results add to re-
cent data that have implicated a3b1 integrin in the regula-
tion of MMP-2 production and invasiveness of rhabdo-
myosarcoma and glioblastoma cells (Chintala et al., 1996;
Kubota et al., 1997). Interestingly, in contrast to these ear-
lier studies, treatment of MDA-MB-231 cells with anti-
a3 or antitetraspanin mAbs did not induce activation
of MMP-2. Furthermore, the expression level and cellu-
lar distribution of MT1-MMP, a membrane-type MMP
known to be crucial for activation of MMP-2 (Birkedal-
Hansen, 1995), were not affected in the mAb-treated cells
(Sugiura, T., and F. Berditchevski, unpublished results).
Thus, it is possible that either a3b1-dependent activation
of MMP-2 in rhabdomyosarcoma cells involves a different
type of a3b1-containing protein complex(es) (that is not
expressed on MDA-MB-231 cells) or the a3b1–tetraspa-
nin-induced signaling pathway is partly deficient in the
breast carcinoma cells.
Although production of MMP-2 is clearly regulated in
both normal and cancer tissues, surprisingly little is known
about the signaling pathways that control this process.
Prostaglandin E2, phorbol esters, and cAMP were shown
to stimulate transcription of MMP-2 in glomerular mesan-
gial cells and fibrosarcoma cells (Marti et al., 1993; Tan-
aka et al., 1995). Notably, we have found that the mAb-
induced production of MMP-2 does not involve the activa-
tion of cAMP-dependent protein kinase, but instead,
requires the activity of PI3K. This suggests that D-3 phos-
phoinositides may be signaling mediators in this process.
Interestingly, an inhibitor of protein tyrosine phosphatases
did not affect the a3b1–tetraspanin-mediated production
of MMP-2. This latter observation leads to two important
conclusions: (a) production of MMP-2 by itself is not suffi-
cient to stimulate protrusive activity of tumor cells; and (b)
signaling pathways leading to the rearrangement of the ac-
tin cytoskeleton and formation of long invasive protru-
sions bifurcate after activation of PI3K.
Finally, an important conclusion that can be drawn from
our study is that there is a functional diversity associated
with various cell surface pools of the a3b1 receptors. In-
deed, although in MDA-MB-231 cells a3b1 integrin is as-
sociated with both tetraspanin and emmprin, only the tet-
raspanin-containing complexes were implicated in the
formation of invasive protrusions and the production of
MMP-2. These observations provide strong evidence for
the idea that the associated protein partners dictate signal-
ing specificity of integrins. On the other hand, our data
clearly indicate that there is a signaling redundancy be-
tween various a3b1–tetraspanin complexes, as all tested
antitetraspanin mAbs induced similar morphological and
biochemical responses. It has been postulated that tet-
raspanins form a network of various interconnected cell
surface complexes, a tetraspan web, which, in fact, may be
considered as one signaling entity (Lagaudriere-Gesbert et
al., 1997; Yáñez-Mó et al., 1998). Thus, our results not only
support this notion, but also highlight a specific signaling
pathway involving the a3b1–tetraspanin protein web. It
should be noted, that in spite of the apparent phenomeno-
logical similarities, there were quantitative differences
(both at the morphological and biochemical levels) in cel-
lular responses to various antitetraspanin mAbs. This may
arise from the unique structural features of a particular
tetraspanin (for example, CD63 possesses a lysosomal tar-
geting signal that may specifically affect a postclustering
internalization of the protein and its most proximal inter-
acting partners) and, consequently, signaling asymmetry
of the web (e.g., there may be differences in spatial prox-
imity of a particular tetraspanin to a specific signaling pro-
tein associated with the web [for example, PI4K]).
Cellular invasion is a complex process controlled by
multiple interconnected signaling pathways (observed ef-
fect of various pharmacological inhibitors in this study),
and may involve different members of the integrin family
of adhesion receptors. Indeed, we have shown here that
not only a3b1 integrin, but also a2b1 integrin may contrib-
ute to the invasive phenotype of the MDA-MB-231 cells.
Importantly, in preliminary experiments we have estab-
lished that although it stimulates cell invasion, the anti-a2
mAb has minimal effect on chemotactic migration of the
MDA-MB-231 cells towards absorbed Matrigel (Sugiura,
T., and F. Berditchevski, unpublished results). This obser-
vation implies that a2b1 integrin is specifically engaged
during migration through the three-dimensional environ-
ment. Although this issue remains open for further investi-
gation, one possibility is that the anti-a2 mAb may affect
transient adhesive interactions between the embedded
cells and polymerized Matrigel. As discussed above, in the
absence of strong attachment points (such as focal adhe-
sions that are assembled in cells migrating on planar sur-
faces), these highly dynamic interactions would have a
dominating role in determining a migratory potential of
the cells.
Production of ECM-degrading enzymes (including
MMPs), reorganization of the actin cytoskeleton (includ-
ing destabilization of the cortical cytoskeleton), and the
ability to generate traction forces are interdependent yet
distinct cellular events that are critical for migration within
three-dimensional ECM. Here we show that a3b1–tet-
raspanin protein complexes may play a crucial role in con-
trolling all three constituents of the invasive process. Thus,
further dissecting the signaling events associated with acti-
vation of the complexes may prove to be important for
better understanding of the molecular mechanisms of tu-
mor cell invasion and metastasis.
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